Category Archives: Complications

Early Vs Delayed Thoracic Endovascular Repair

Back in the day, the only way to fix a broken thoracic aorta was via left thoracotomy.  This was a big procedure, with the possibility of several major complications, with postop paraplegia being one of them. At the time, there was a debate about whether the procedure should be done immediately versus waiting until the patient was well-resuscitated. The concern was that death was nearly certain if the aortic lesion progressed.

We learned that temporizing with strict blood pressure control worked wonders at protecting the patient. Although many of these injuries were managed within hours, a growing number were delayed by a few days to improve outcomes.

Nowadays, thoracic endovascular aortic repair (TEVAR) is routine and much less morbid than the open procedure. However, the same question arises: do it early or wait a while? Interestingly, not one but two analyses have been published on this very topic in the last four months!

The first is from an international research group that searched the usual databases and initially found 921 records. They included only clinical trials or cohort studies with ten or more adult patients that could be stratified as early (within 24 hours) or late (after 24 hours) intervention. After applying these criteria, only seven studies remained for analysis.

There were 3,757 patients with early repairs, compared to 1,238 undergoing late repair. The presenting demographics and injury grades were similar in each group. However, the short-term mortality was significantly higher (1.9x) in the early TEVAR group. Additionally, ICU length of stay was significantly longer (3 days) in the late TEVAR group.

The second paper was presented as a quick-shot at last year’s AAST meeting. It is from a group of researchers from our big Boston trauma centers and the Netherlands. They used four years of data from the TQIP database, giving them extra information unavailable in the first study. They specifically looked at patients with grade II or III injuries. Here is the grading scale:

Here are the factoids:

  • A total of 1,339 patients were studied, with about three-quarters in the early TEVAR group
  • Median time to TEVAR was 4 hours in the early group and 65 hours in the late group
  • Patients in the early group were significantly less likely to have brain or liver injuries
  • ISS was similar in both groups
  • The early TEVAR group had significantly higher in-hospital mortality (16% vs. 5%), significantly higher risk of ARDS (7.6% vs. 2.1%), but significantly shorter ICU stay (7 vs 10 days)
  • When patients who died within the first 24 hours were excluded, the in-hospital mortality remained significantly higher, and the ICU and hospital lengths of stay were significantly shorter

Bottom line: Some society guidelines began recommending delayed TEVAR in 2015. This study did not detect any trend toward this, however. Using different methods and databases, these two studies identified nearly identical mortality and ICU trends in large groups of patients. The mortality trends do not appear to be related to injury grade, overall injury severity, or the presence of head injury. 

Taken together, this suggests that we need to rethink the timing of TEVAR in patients with grade II or III injuries. The best timing still needs to be defined, but it appears to be beyond 24 hours. Centers performing this procedure should review their results and consider extending procedure timing as additional research is done to define the ideal time interval.

References:

  1. Early Versus Delayed Thoracic Endovascular Aortic Repair for Blunt Traumatic Aortic Injury: A Systematic Review and Meta-Analysis. Cureus. 2023 Jun 28;15(6):e41078. doi: 10.7759/cureus.41078. PMID: 37519486; PMCID: PMC10375940.
  2. Early Versus Delayed Thoracic Endovascular Aortic Repair for
    Blunt Thoracic Aortic Injury: A Propensity Score-Matched Analysis. Ann Surg 278:e848-e854, 2023.

 

Print Friendly, PDF & Email

Back Braces: Are They Really Needed?

Back braces have always confused me. There are so many types: TLSO, LSO, backpack, extension, and even the lowly abdominal binder can function as a brace. And I have never been able to predict which brace my spine colleagues accurately would prescribe for a specific condition or injury.

Many vertebral fractures can be treated non-operatively. And it seems intuitive that there would be some benefit from splinting the spine to limit the range of motion to enhance healing. So I would like to concentrate on some papers that examined the use of back braces on patients who underwent pedicle screw fixation of their thoracic and/or lumbar spine fractures. 

I found two systematic reviews and a ten-year prospective clinical trial. First, the reviews.

The first was published in 2016 and examined papers comparing postop bracing vs. no postop bracing. It looked at loss of deformity correction, return to work, functional improvement, instrumentation failure rate, pseudoarthrosis, and postop complications. A total of 76 studies were included.

The average wear time for the braces was just over three months. There was no difference in pain, return to work, functional outcome, or instrumentation failure. Interestingly, there was a significant increase in the number of patients who lost kyphotic reduction from the procedure and a significant increase in the number of complications. Unfortunately, the authors did not break out specific complications other than wound infections. Although these were higher in the braced group (2.8% vs. 1.8%), this difference was not significant. One real positive for the brace: the number of pseudoarthroses was significantly less (2.4% vs. 6%).

The next review looked at postoperative bracing from a cost-effectiveness standpoint. It considered adverse events such as infections and hardware failure and examined a total of 1957 patients across 48 papers. Non-braced patients were somewhat older. Braced patients had significantly fewer reoperations for non-union or hardware failure (1.3% vs. 1.8%). There was no difference in wound dehiscence or infection. Overall, there was no cost benefit to applying a back brace in these patients after pedicle screw fixation. 

The last paper was a prospective clinical trial that enrolled 144 patients randomized to brace or no brace after their surgical procedure. They underwent multiple postop evaluations to monitor quality of life, success of the fusion, pain, mobility, and return to previous activities.

Here are the factoids:

  • Mean age was only 34 years, and only fractures of T11 to L5 were included
  • Two-thirds of the injuries were due to falls, and most of the remaining ones were from car crashes
  • Three-quarters were burst fractures, and the remaining were wedge or fracture-dislocation injuries
  • There were no differences in early mobilization, residual pain, return to previous activities, quality of life, or success of the fusion after one year

The authors concluded that the use (or non-use) of a TLSO brace after pedicle screw fixation of these fractures does not affect treatment. They state that TLSO braces are not required in the postop period for these patients.

Bottom line: Interesting, yet slightly confusing. The systematic reviews show a significant increase in pseudoarthrosis in patients without braces. This was not seen in the prospective study. The discrepancy could be due to the quality of the papers included in the reviews or insufficient power in the prospective study. So it may be too early to fully know the difference. But it appears to be so small that the question of whether a brace is really necessary needs to be asked. 

Most braces are expensive and uncomfortable. I have seen several patients in follow-up who basically stopped wearing their brace as soon as they were out of the hospital. And anecdotally, they did fine. 

A large, multicenter study in progress in the Netherlands will analyze the same factors listed above.  Unfortunately, the listing on clinicaltrials.gov indicates they are only recruiting 45 patients, which may not add much to what is already known due to low statistical power.

In the meantime, consider discussing with your spine surgeons reviewing the current literature on back bracing. It may be possible to reduce the number of eligible patients who take their brace home and use it as a chew toy for the dog. 

References:

  1. Bracing After Surgical Stabilization of Thoracolumbar Fractures: A Systematic Review of Evidence, Indications, and Practices. World Neurosurg 93:221-228, 2016.
  2. Post-operative bracing after pedicle screw fixation for thoracolumbar burst fractures: A cost-effectiveness study. J Clin Neurosci 45:33-39, 2017.
  3. Evaluation of postoperative bracing on unstable traumatic lumbar fractures after pedicle screw fixation. Int J Burns Trauma 12(4):168-174, 2022.
  4. Is postoperative bracing after pedicle screw fixation of spine fractures necessary? Study protocol of the ORNOT study: a randomised controlled multicentre trial. NCT03097081. Listed in 2017, to be completed Nov 2026.
Print Friendly, PDF & Email

How Much Fetal Radiation Exposure In Imaging Studies?

I periodically publish a chart that shows how much radiation exposure our patients get from various trauma imaging studies. For reference, here it is:

Test Dose (mSv) Equivalent background
radiation
Chest x-ray 0.1 10 days
Pelvis x-ray 0.1 10 days
CT head 2 8 months
CT cervical spine 3 1 year
Plain c-spine 0.2 3 weeks
CT chest 7 2 years
CT abdomen/pelvis 10 3 years
CT T&L spine 7 2 years
Plain T&L spine 3 1 year
Millimeter wave
scanner (that hands
in the air TSA thing at
the airport)
0.0001 15 minutes
Scatter from a chest
x-ray in trauma bay
when standing one 
meter from the
patient
0.0002 45 minutes
Scatter from a chest
x-ray in trauma bay
when standing three 
meters from the
patient
0.000022 6 minutes

One of the issues that trauma professionals gnash our teeth about is how much radiation the baby gets when we perform these studies on pregnant women. Well, here is just what you need. Another chart! In order to avoid confusion, I will list effective doses to the fetus in milligrays (mGy), which is how much radiation is deposited in a substance. This is a little confusing, since doses are frequently listed in millisieverts which takes the specific organ and type of radiation into effect. In general, these two units are very similar for x-rays.

A useful rule of thumb is that if the fetal dose is less than 50 mGy during any trimester, the risk of an abortion or fetal malformation is about the same as from other risks to the pregnancy. The American College of Radiology notes that exposures less than 100 mGy are “probably too subtle to be clinically detectable.”

To help in your clinical decision making, I’ve added some extra information to the table regarding fetal exposure:

Test Adult Dose (mSv) Fetal Dose (mGy)
Chest x-ray 0.1 negligible
Pelvis x-ray 0.1 negligible
CT head 2 <1
CT head and C-spine 4 10
CT chest 7 <1
CT abdomen/pelvis 10 25
Pan Scan (CTA chest, abdomen, and pelvis) up to 68 up to 56
CT pulmonary angiogram up to 40 <1

Bottom line: We still have to think hard about how we image pregnant patients! There are some alternatives available to us, including the good old physical exam, conventional x-rays, and ultrasound. MRI is possible, but is a pain in the ass for many reasons. 

CT of the head and cervical spine are fine for both mother and baby, and non-contrast imaging of the torso is within accepted limits of fetal exposure. However, the whole point of the torso scan in CT is to identify critical injuries that may lead to exsanguination like solid organ and aortic injuries. In general, those scans should always be ordered with contrast. 

If clinical suspicion is high, it may be necessary to order these higher-dose studies anyway. If the mother has an unrecognized and potentially fatal injury, the baby will not survive either. There are many, many permutations of injuries and diagnostics. These cases will put your clinical judgment to the test, for sure!

References:

  • Imaging Pregnant and Lactating patients. RadioGraphics 35:6, 1751-1765, 2015.
  • Imaging of the pregnant trauma patient. RadioGraphics 34:3, 748-763,2014.
  • Fetal doses from radio logical examinations. Br J Radiol;72(860): 773–780, 1999.
Print Friendly, PDF & Email

Best Of AAST #6: Chronic Disease In Young Trauma Patients

Worldwide, the proportion of older people is growing. With that is an increase in the number of older folks with medical comorbidities like diabetes, hypertension, and obesity. Trauma professionals recognize these conditions’ negative impact on recovery after injury.

But is being young becoming the new old? The trauma group at WakeMed performed a retrospective multi-center study to tease out an estimate of the prevalence of these conditions (plus one more: alcohol/substance use) in injured young(er) people. They studied trauma patients aged 18-40 over three years, examining their charts for evidence of the conditions listed that had been previously undiagnosed.

Here are the factoids:

  • Of the 6,307 patients included, a startling 4,843 (77%) had at least one underlying disease, usually hypertension or obesity
  • Using their multivariate models, they found that age was (barely) a predictor, as were male sex ( 1.43x) and uninsured status (1.6x)
  • Only a quarter of patients had a primary care physician (PCP), but this did not increase the presence of underlying disease
  • Patients found to have these conditions were twice as likely to be referred to a PCP, although this referral rate was still very low (14% vs. 8%)
  • There was no difference in inpatient complications or hospital length of stay

The authors concluded that the undiagnosed disease burden in young adult trauma patients is high. They recommend rigorous screening measures and appropriate referrals.

Bottom line: This is an interesting abstract revealing what we all probably subconsciously recognize. Younger people are not as healthy as they once were. The numbers with obesity, diabetes, hypertension, and substance use are now staggering, with over three-quarters of patients in this convenience study impacted.

Abnormalities are often found on the lab panels drawn during a trauma activation or upon admission. Unfortunately, we do not always act on them since they don’t appear to have anything to do with the trauma.

This abstract makes it clear that the disease burden in this group is high. It is very likely that those affected will probably develop complications at an earlier age and will suffer a decrease in their overall healthspan as they age. The only and most important thing we can do is pay attention and set our patients up with a primary care physician on discharge to begin working on their potential health problems.

Print Friendly, PDF & Email

Leukocytosis After Splenic Injury

Any trauma professional who has dealt with spleen injuries knows that the white blood cell (WBC) count rises afterwards. And unfortunately, this elevation can be confusing if the patient is at risk for developing inflammatory or infectious processes that might be monitored using the WBC count.

Is there any rhyme or reason to how high WBCs will rise after injury? What about after splenectomy or IR embolization? An abstract is being presented at the Clinical Congress of the American College of Surgeons next month that examines this phenomenon.

This retrospective study looked at a convenience sample of 75 patients, distributed between patients who had splenic injury that was either not treated, removed (splenectomy), or embolized. Data points were accumulated over 45 days.

Here are the factoids:

  • 20 patients underwent splenectomy, 22 were embolized, and 33 were observed and not otherwise treated
  • Injury severity score was essentially identical in all groups (19)
  • Splenectomy caused the highest WBC counts at the 30 day mark (17.4K)
  • Embolized patients had mildly elevated WBC levels (13.1K) that were just above the normal range at 30 days
  • Observed patients had high normal WBC values (11.0K) after 30 days
  • Values in observed and embolized patients normalized to about 7K after 30 days; splenectomy patient WBC count remained mildly elevated at 14.1K.
  • The authors concluded that embolization does not result in permanent loss of splenic function (bad conclusion, rookie mistake!)

Bottom line: This study is interesting because it gives us a glimpse of the time course of leukocytosis in patients with injured spleens. If you need to follow the WBC for other reasons, if gives a little insight into what might be attributable to the spleen. Splenectomy generally results in a chronically elevated WBC count, which tends to vary in the mid-teens range. Embolization (in this study) transiently elevates the WBC count, but it then drops back to normal.

The big problem with this study (besides it being small) is that it fails to recognize that there are many different shades of embolization. Splenic artery? Superselective? Selective? I suspect that the WBC count in main splenic artery embolization may behave much like splenectomy in terms of leukocytosis. And the conclusion about splenic function being related to WBC count was pulled out of a hat. Don’t believe it.

Reference: Leukocytosis after Splenic Injury: A Comparison of Splenectomy, Embolization, and Observation. American College of Surgeons Scientific Forum Abstracts pg S164, 2015.

Print Friendly, PDF & Email